Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
6.01
-0.23 (-3.69%)
At close: May 18, 2026, 4:00 PM EDT
6.04
+0.03 (0.50%)
After-hours: May 18, 2026, 7:29 PM EDT
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of $1.04 billion as of May 18, 2026. Its market cap has increased by 40.87% in one year.
Market Cap
1.04B
Enterprise Value
1.18B
1-Year Change
40.87%
Ranking
Category
Stock Price
$6.01
Market Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from $295.78M to $1.04B, an increase of 250.80%. That is a compound annual growth rate of 31.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 1.04B | -20.34% |
| Dec 31, 2025 | 1.30B | 157.72% |
| Dec 31, 2024 | 505.39M | 55.70% |
| Dec 29, 2023 | 324.59M | 79.47% |
| Dec 30, 2022 | 180.86M | -50.50% |
| Dec 31, 2021 | 365.40M | 23.54% |
| Oct 6, 2021 | 295.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amylyx Pharmaceuticals | 1.48B |
| Perrigo Company | 1.47B |
| Phibro Animal Health | 1.39B |
| Harrow | 1.16B |
| Collegium Pharmaceutical | 1.10B |
| Alvotech | 1.04B |
| Cronos Group | 987.05M |
| Evotec SE | 953.92M |